Oncologist Dr. Belinda Yeoh and a patient


Professor Andrew Scott receives $200,000 grant to fuel brain cancer breakthrough

Austin Health cancer researcher receives brain cancer grant

Professor Andrew Scott
Professor Andrew Scott
Austin Health cancer researcher Professor Andrew Scott is to lead one of just two cutting-edge research projects to receive one of the Cure Brain Cancer Foundation's $200,000 innovation grants.

The Foundation funds projects that break from traditional research paradigms and have the potential to fuel much-needed breakthroughs - and ultimately, improve brain cancer survival.

Professor Andrew Scott, who holds positions at Austin Health and the Olivia Newton-John Cancer Research Institute (La Trobe University School of Cancer Medicine) will lead a research team that will work on improving prognosis for the brain cancer glioblastoma. It is hoped that the trial will lead to the better prediction of a patient's likely response to therapy, along with their likelihood of resistance to treatment.

The team aims to achieve this by utilising an imaging technique for detecting amino acid metabolism in brain tumours using Positron Emission Tomography, in a clinical trial of over 200 patients.

"The Cure Brain Cancer Foundation grant is enabling sophisticated image analysis of PET and MRI scans in patients participating in a multi-centre Medical Research Future Fund (MRFF) funded trial, which we hope will allow more accurate treatment and improve glioblastoma patient outcomes," says Prof. Scott.

Brain cancer is a devastating illness with few effective treatment options. The Cure Brain Cancer Foundation provides funding to rapidly increase Australian brain cancer research capacity, and has provided grants of more than $1 million to brain cancer researchers in the past year alone.

These week's two $200,000 Innovation Grants were given to Professor Andrew Scott of Austin Health and the Olivia Newton-John Cancer Research Institute (La Trobe University School of Cancer) and Associate Professor Lee Wong of Monash University, following a high quality and competitive application process.

Michelle Stewart, CEO of Cure Brain Cancer Foundation said, "These projects are at the cutting-edge of brain cancer research, doing things differently to improve outcomes for brain cancer patients. We must support these innovative projects if we're going to rapidly improve brain cancer survival."

Since 2013, Cure Brain Cancer Foundation has committed more than $18 million to brain cancer research, backing 41 research projects and enabled the investigation of almost 120,000 drugs.